Freshfields and Wachtell steer AstraZeneca/Alexion
Shutterstock/Ascannio
AstraZeneca has tapped Freshfields Bruckhaus Deringer to guide its $39 billion acquisition of Alexion Pharmaceuticals, which is being advised by Wachtell Lipton Rosen & Katz.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10